Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review.
Nasser M AlorfiAlanood S AlgarniPublished in: Clinical pharmacology : advances and applications (2022)
The findings from the review suggest that semaglutide appears to be beneficial, most notably in its contribution to weight reduction.